Drosophila PI3 kinase and Akt involved in insulin-stimulated proliferation and ERK pathway activation in Schneider cells

Sung Eun Kim; Jae Young Cho; Kyung Sup Kim; Su Jae Lee; Ki Hoo Lee; Kang Yell Choi

doi:10.1016/j.cellsig.2004.04.004

Drosophila PI3 kinase and Akt involved in insulin-stimulated proliferation and ERK pathway activation in Schneider cells

Sung Eun Kim, Jae Young Cho, Kyung Sup Kim, Su Jae Lee, Ki Hoo Lee, Kang Yell Choi

Research output: Contribution to journal › Article › peer-review

22 Citations (Scopus)

Abstract

We have characterized the role of Drosophila PI3K and AKT in ERK pathway activation involving insulin-induced proliferation using Drosophila Schneider cells. After insulin treatment, dPI3K and dAKT activities were both increased along with activation of the dERK pathway components dMEK and dERK. The insulin-induced activations of dERK and dAKT were blocked by LY294002, dPTEN, and by an AKT inhibitor, indicating involvement of dPI3K and dAKT in the insulin-induced dERK and dAKT activations. Proliferation and the G1 to S phase cell cycle progression due to insulin were also blocked by PI3K and AKT inhibitors, indicating that the Drosophila PI3K-AKT pathway involves insulin-mediated cell proliferation. The insulin-stimulated size increase was blocked by both LY294002 and AKT inhibitor, not by U0126, indicating that insulin-mediated size control by dPI3K and dAKT occurs independently of the ERK pathway. This study indicates that dPI3K and dAKT are involved in insulin-induced ERK pathway activation leading to proliferation in Drosophila Schneider cells.

Original language	English
Pages (from-to)	1309-1317
Number of pages	9
Journal	Cellular Signalling
Volume	16
Issue number	11
DOIs	https://doi.org/10.1016/j.cellsig.2004.04.004
Publication status	Published - 2004 Nov

Bibliographical note

Funding Information:
This work was supported by grants from The Molecular and Cellular BioDiscovery Research Program (M1-0311-00-0111), the Korea Research Foundation Grant (KRF-2003-2003-015-C00400), and the Korea Science and Engineering Foundation through the Protein Network Research Center at Yonsei University to K.Y. Choi.

All Science Journal Classification (ASJC) codes

Cell Biology

Access to Document

10.1016/j.cellsig.2004.04.004

Fingerprint Dive into the research topics of 'Drosophila PI3 kinase and Akt involved in insulin-stimulated proliferation and ERK pathway activation in Schneider cells'. Together they form a unique fingerprint.

Cite this

@article{6912c357494e4004ad10de1d584ade3b,

title = "Drosophila PI3 kinase and Akt involved in insulin-stimulated proliferation and ERK pathway activation in Schneider cells",

abstract = "We have characterized the role of Drosophila PI3K and AKT in ERK pathway activation involving insulin-induced proliferation using Drosophila Schneider cells. After insulin treatment, dPI3K and dAKT activities were both increased along with activation of the dERK pathway components dMEK and dERK. The insulin-induced activations of dERK and dAKT were blocked by LY294002, dPTEN, and by an AKT inhibitor, indicating involvement of dPI3K and dAKT in the insulin-induced dERK and dAKT activations. Proliferation and the G1 to S phase cell cycle progression due to insulin were also blocked by PI3K and AKT inhibitors, indicating that the Drosophila PI3K-AKT pathway involves insulin-mediated cell proliferation. The insulin-stimulated size increase was blocked by both LY294002 and AKT inhibitor, not by U0126, indicating that insulin-mediated size control by dPI3K and dAKT occurs independently of the ERK pathway. This study indicates that dPI3K and dAKT are involved in insulin-induced ERK pathway activation leading to proliferation in Drosophila Schneider cells.",

author = "Kim, {Sung Eun} and Cho, {Jae Young} and Kim, {Kyung Sup} and Lee, {Su Jae} and Lee, {Ki Hoo} and Choi, {Kang Yell}",

note = "Funding Information: This work was supported by grants from The Molecular and Cellular BioDiscovery Research Program (M1-0311-00-0111), the Korea Research Foundation Grant (KRF-2003-2003-015-C00400), and the Korea Science and Engineering Foundation through the Protein Network Research Center at Yonsei University to K.Y. Choi.",

year = "2004",

month = nov,

doi = "10.1016/j.cellsig.2004.04.004",

language = "English",

volume = "16",

pages = "1309--1317",

journal = "Cellular Signalling",

issn = "0898-6568",

publisher = "Elsevier Inc.",

number = "11",

}

TY - JOUR

T1 - Drosophila PI3 kinase and Akt involved in insulin-stimulated proliferation and ERK pathway activation in Schneider cells

AU - Kim, Sung Eun

AU - Cho, Jae Young

AU - Kim, Kyung Sup

AU - Lee, Su Jae

AU - Lee, Ki Hoo

AU - Choi, Kang Yell

N1 - Funding Information: This work was supported by grants from The Molecular and Cellular BioDiscovery Research Program (M1-0311-00-0111), the Korea Research Foundation Grant (KRF-2003-2003-015-C00400), and the Korea Science and Engineering Foundation through the Protein Network Research Center at Yonsei University to K.Y. Choi.

PY - 2004/11

Y1 - 2004/11

N2 - We have characterized the role of Drosophila PI3K and AKT in ERK pathway activation involving insulin-induced proliferation using Drosophila Schneider cells. After insulin treatment, dPI3K and dAKT activities were both increased along with activation of the dERK pathway components dMEK and dERK. The insulin-induced activations of dERK and dAKT were blocked by LY294002, dPTEN, and by an AKT inhibitor, indicating involvement of dPI3K and dAKT in the insulin-induced dERK and dAKT activations. Proliferation and the G1 to S phase cell cycle progression due to insulin were also blocked by PI3K and AKT inhibitors, indicating that the Drosophila PI3K-AKT pathway involves insulin-mediated cell proliferation. The insulin-stimulated size increase was blocked by both LY294002 and AKT inhibitor, not by U0126, indicating that insulin-mediated size control by dPI3K and dAKT occurs independently of the ERK pathway. This study indicates that dPI3K and dAKT are involved in insulin-induced ERK pathway activation leading to proliferation in Drosophila Schneider cells.

AB - We have characterized the role of Drosophila PI3K and AKT in ERK pathway activation involving insulin-induced proliferation using Drosophila Schneider cells. After insulin treatment, dPI3K and dAKT activities were both increased along with activation of the dERK pathway components dMEK and dERK. The insulin-induced activations of dERK and dAKT were blocked by LY294002, dPTEN, and by an AKT inhibitor, indicating involvement of dPI3K and dAKT in the insulin-induced dERK and dAKT activations. Proliferation and the G1 to S phase cell cycle progression due to insulin were also blocked by PI3K and AKT inhibitors, indicating that the Drosophila PI3K-AKT pathway involves insulin-mediated cell proliferation. The insulin-stimulated size increase was blocked by both LY294002 and AKT inhibitor, not by U0126, indicating that insulin-mediated size control by dPI3K and dAKT occurs independently of the ERK pathway. This study indicates that dPI3K and dAKT are involved in insulin-induced ERK pathway activation leading to proliferation in Drosophila Schneider cells.

UR - http://www.scopus.com/inward/record.url?scp=4444347661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444347661&partnerID=8YFLogxK

U2 - 10.1016/j.cellsig.2004.04.004

DO - 10.1016/j.cellsig.2004.04.004

M3 - Article

C2 - 15337530

AN - SCOPUS:4444347661

VL - 16

SP - 1309

EP - 1317

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

IS - 11

ER -

Drosophila PI3 kinase and Akt involved in insulin-stimulated proliferation and ERK pathway activation in Schneider cells

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this